PODDStockInsulet Corporation
Verdicts genuinely change. Free email alert the moment PODD's does — no target price to set, unlike a price alert.
Stable Ratio screen, 6 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Trade plan
Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Insulet Corporation (PODD) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-12). See the full ratio breakdown and business-activity screen below for the reasoning.
This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →
How the status reached this point
Compliant · status tracked since Nov 17, 2026
No change to PODD’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.
Read once a day from our own screen, last on Nov 18, 2026. The per-methodology record is under “What changed, and when” in the in-house research.
🕌 In-house Compliance Research
Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.
AAOIFI divides by the market cap: $10.1B as of 2026-11-18.
Business activity: cleared (no excluded categories detected)
AAOIFI Pass 3 of 3 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 9.54% | 30.00% | Pass(20.5pp buffer) |
| Interest-bearing investments | 5.80% | 30.00% | Pass(24.2pp buffer) |
| Non-permissible income | 1.28% | 5.00% | Pass(3.7pp buffer) |
Usmani Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 28.17% | 33.00% | Pass(4.8pp buffer) |
| Interest-bearing investments | 17.11% | 33.00% | Pass(15.9pp buffer) |
| Non-liquid assets | 62.71% | at least 20.00% | Pass(42.7pp above the floor) |
| Non-permissible income | 1.28% | 5.00% | Pass(3.7pp buffer) |
MSCI Fail 3 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 28.17% | 33.33% | Pass(5.2pp buffer) |
| Cash + interest-bearing securities | 17.11% | 33.33% | Pass(16.2pp buffer) |
| Accounts receivable | 37.29% | 33.33% | Fail(4.0pp over) |
| Non-permissible income | 1.28% | 5.00% | Pass(3.7pp buffer) |
FTSE Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 28.17% | 33.33% | Pass(5.2pp buffer) |
| Cash + interest-bearing securities | 17.11% | 33.33% | Pass(16.2pp buffer) |
| Accounts receivable | 37.29% | 50.00% | Pass(12.7pp buffer) |
| Non-permissible income | 1.28% | 5.00% | Pass(3.7pp buffer) |
Dow Jones Islamic Market Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 5.50% | 33.00% | Pass(27.5pp buffer) |
| Cash + interest-bearing securities | 3.34% | 33.00% | Pass(29.7pp buffer) |
| Accounts receivable | 3.94% | 33.00% | Pass(29.1pp buffer) |
| Non-permissible income | 1.28% | 5.00% | Pass(3.7pp buffer) |
S&P Shariah Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 5.88% | 33.00% | Pass(27.1pp buffer) |
| Cash + interest-bearing securities | 3.57% | 49.00% | Pass(45.4pp buffer) |
| Accounts receivable | 4.21% | 49.00% | Pass(44.8pp buffer) |
| Non-permissible income | 1.28% | 5.00% | Pass(3.7pp buffer) |
MSCI M-Series Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 5.88% | 33.33% | Pass(27.5pp buffer) |
| Cash + interest-bearing securities | 3.57% | 33.33% | Pass(29.8pp buffer) |
| Accounts receivable | 7.78% | 49.00% | Pass(41.2pp buffer) |
| Non-permissible income | 1.28% | 5.00% | Pass(3.7pp buffer) |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
How close is it to flipping?
Every current reading against its own line, closest first. A verdict is only as durable as that distance.
The numbers the ratios are built from
Read from PODD's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.
| Line | Figure | As reported | Read from |
|---|---|---|---|
| RevenueTotal revenue for the period | $2.7B | 2025-12-31 | Revenues |
| Interest-bearing debtShort and long-term borrowings | $962.1M | 2026-09-30 | LongTermDebtAndCapitalLeaseObligations, LongTermDebtCurrent |
| Cash and interest-bearing securitiesCash, equivalents and marketable securities | $584.4M | 2026-09-30 | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
| Total assetsBalance sheet total | $3.4B | 2026-09-30 | Assets |
| Market capDenominator for AAOIFI | $10.1B | live quote | price x shares |
| 36-month average market capDenominator for S&P Shariah and MSCI M-Series | $16.0B | 756 trading days | closes x shares |
| 24-month average market capDenominator for Dow Jones Islamic Market | $17.1B | 504 trading days | closes x shares |
| Non-permissible revenueInterest and excluded income | $34.7M | 2025-12-31 | InvestmentIncomeInterest |
Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.
Sources
Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-04, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-02-18, period ended 2025-12-31. Screened 2026-11-18.
-
Total assets$3.4B
Assets· period ended 2026-09-30 · 10-Q filed 2026-11-04 -
Interest-bearing debt$962.1M
LongTermDebtAndCapitalLeaseObligations$943.0M · period ended 2026-09-30 · 10-Q filed 2026-11-04LongTermDebtCurrent$19.1M · period ended 2026-09-30 · 10-Q filed 2026-11-04 -
Cash and interest-bearing securities$584.4M
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents· period ended 2026-09-30 · 10-Q filed 2026-11-04 -
Receivables$689.0M
AccountsReceivableNetCurrent· period ended 2026-09-30 · 10-Q filed 2026-11-04 -
Revenue$2.7B
Revenues· period ended 2025-12-31 · 10-K filed 2026-02-18 -
Interest income (non-permissible)$34.7M
InvestmentIncomeInterest· period ended 2025-12-31 · 10-K filed 2026-02-18 -
Market cap$10.1BMarket quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-18 · not a filing figure, so no link
7 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.
What changed, and when
Verdict history for PODD. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for PODD has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
Tracked since 2026-09-07.
Revenue by business segment
How PODD’s $2.7B of revenue for the fiscal year 2025-01-01 to 2025-12-31 splits across what it sells, as the company tags it in its own 10-K.
| Segment | Share | Revenue |
|---|---|---|
| U.S. | 70.9% | $1.9B |
| International | 27.9% | $754.3M |
| Drug Delivery | 1.3% | $34.1M |
These are the company’s own segment names and figures. They do not say whether a line of business is permissible; our business-activity screen does.
Source: 10-K filed 2026-02-18 (accession 0001145197-26-000028), read from its XBRL on SEC EDGAR. Shares are of total revenue; subtotals and overlapping cuts the filing also tags are left out, so the lines add up to the total.
What would change the status
The headline verdict is the majority of the decided ratio standards — 6 pass and 1 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-18.
No standard's deciding ratio sits within 3 points of its line.
The ratios that move with the share price
AAOIFI's debt ratio (9.5% against a 30% line) would only fail if the market cap fell by 68%, to $3.2B.
AAOIFI's investments ratio (5.8% against a 30% line) would only fail if the market cap fell by 81%, to $1.9B.
Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.
Shariah-compliant alternatives
Compliant companies in Medical Devices listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.
| Company | Market cap | Price, day |
|---|---|---|
| ABTAbbott Laboratories | $201.9B | — |
| SYKStryker Corp. | $125.7B | — |
| MDTMedtronic Plc | $117.8B | — |
| BSXBoston Scientific Corp. | $71.0B | — |
| EWEdwards Lifesciences Corp | $52.2B | — |
A dash means no fresh quote is cached for that symbol; this list does not fetch one.
Funds that hold PODD
16 of the 182 funds whose filed holdings we currently hold own PODD shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns PODD.
Shariah funds| Fund | PODD in fund | Fund compliant by weight |
|---|---|---|
| MNZL Manzil Russell Halal USA Broad Market ETF | 0.03% | 88% |
| HLAL Wahed FTSE USA Shariah ETF | 0.03% | 72% |
| SPUS SP Funds S&P 500 Sharia Industry Exclusions ETF | 0.02% | 79% |
Widely held U.S. index funds. If you own one, you own PODD through it. None of them is a Shariah fund; the last column is our look-through of each.
| Fund | PODD in fund | Fund compliant by weight |
|---|---|---|
| RSP Invesco S&P 500 Equal Weight ETF | 0.21% | 44% |
| IWF iShares Russell 1000 Growth ETF | 0.03% | 69% |
| SPY | 0.02% | 56% |
| SPYM State Street(R) SPDR(R) Portfolio S&P 500(R) ETF | 0.02% | 56% |
| VOO VANGUARD 500 INDEX FUND | 0.02% | 56% |
| IVV iShares Core S&P 500 ETF | 0.02% | 56% |
| ITOT iShares Core S&P Total U.S. Stock Market ETF | 0.01% | 54% |
| VTI VANGUARD TOTAL STOCK MARKET INDEX FUND | 0.01% | 54% |
| SCHB Schwab U.S. Broad Market ETF | 0.01% | 53% |
| Fund | PODD in fund | Fund compliant by weight |
|---|---|---|
| QCELX AQR Large Cap Multi-Style Fund | 0.13% | not computed |
| STXF Strive 500 ETF | 0.02% | 56% |
| PHDG Invesco S&P 500 Downside Hedged ETF | 0.02% | 43% |
| GARUX Goldman Sachs Absolute Return Tracker Fund | 0.01% | not computed |
Sorted by PODD’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names PODD once, so a bond is not counted as the shares; 1 more fund name PODD in a way we cannot separate from its bonds, and is not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| David Shaw | D. E. Shaw & Co. | $199M | 0.1% | 2026-09-30 |
| Ken Griffin | Citadel Advisors | $124M | 0.0% | 2026-09-30 |
| Israel Englander | Millennium Management | $85M | 0.0% | 2026-09-30 |
| Baillie Gifford | Baillie Gifford & Co | $60M | 0.1% | 2026-09-30 |
| Peter Brown | Renaissance Technologies | $41M | 0.1% | 2026-09-30 |
| Paul Tudor Jones | Tudor Investment Corp | $41M | 0.1% | 2026-09-30 |
| Joel Greenblatt | Gotham Asset Management | $28M | 0.1% | 2026-09-30 |
| Ray Dalio | Bridgewater Associates | $11M | 0.0% | 2026-09-30 |
| Louis Bacon | Moore Capital Management | $2M | 0.0% | 2026-09-30 |
| Jefferies | Jefferies Financial Group | $2M | 0.0% | 2026-09-30 |
| Azzad Asset Management | Azzad Asset Management | $1M | 0.1% | 2026-09-30 |
| Steven Cohen | Point72 Asset Management | $1M | 0.0% | 2026-09-30 |
| Ron Baron | Baron Capital (BAMCO) | $0M | 0.0% | 2026-09-30 |
| Wahed Invest | Wahed Invest LLC | $0M | 0.0% | 2026-06-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 42.00 | NEUTRAL |
| Stochastic %K (14) | 2.10 | BUY |
| CCI (20) | -183.70 | BUY |
| Williams %R (14) | -97.90 | BUY |
| MACD (12,26,9) | -1.56 | SELL |
| ROC (10) | -15.17 | SELL |
| Momentum (10) | -25.04 | SELL |
| EMA (10) | 147.37 | SELL |
| SMA (10) | 148.29 | SELL |
| EMA (20) | 147.57 | SELL |
| SMA (20) | 150.19 | SELL |
| EMA (30) | 146.70 | SELL |
| SMA (30) | 146.39 | SELL |
| EMA (50) | 146.11 | SELL |
| SMA (50) | 142.20 | SELL |
| EMA (100) | 152.46 | SELL |
| SMA (100) | 147.90 | SELL |
| EMA (200) | 182.75 | SELL |
| SMA (200) | 171.04 | SELL |
About Insulet Corporation
Healthcare · Medical Devices
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Background via Yahoo Finance — informational, not part of the verdict.
Latest Signal — 2026-11-16
Stop 148.95 Now 139.98 Target 159.54
🟢 STRONG BUY SETUP
Strong confluence across multiple layers — outperforming the market by 7.2%, RSI in healthy zone, insiders buying with real money. High conviction entry. Use `!plan PODD [entry] [stop] [target]` to size the position properly.
Scores: 4 bullish / 1 bearish
No real edge — avoid
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 64 |
| ⏰ 4H | BEARISH | 40 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BULLISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
BULLISH 1 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.